Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spring Bank
Biotech
F-star set to land Nasdaq listing through Spring Bank merger
The merger comes months after a death in Spring Bank’s phase 2b hepatitis B trial torpedoed the biotech’s stock.
Nick Paul Taylor
Jul 30, 2020 7:30am
Spring Bank scraps hep B program after patient death
Jan 29, 2020 3:45pm
Fresh off Amgen deal, Arrowhead pairs with microcap Spring Bank in HBV
Oct 6, 2016 10:07am
Spring Bank Pharma, Oncobiologics discount IPOs
Apr 28, 2016 5:50am